To the Editor:
I read with great interest and with some concern the paper by Cao et al1 that compared volume-controlled and pressure-limited noninvasive ventilation (NIV) in subjects with acute hypercapnic respiratory failure. The authors reported on PaO2/FIO2 rather than PaO2 as part of their baseline demographics in Table 1 and in their results in Figure 5. The methods for NIV described that supplemental oxygen was delivered through a port in the mask with flow adjusted to maintain oxygen saturation using a specific machine (FLEXO ST30, Curative Medical Technology, Suzhou, China). They used a formula to determine FIO2 delivered to each subject and reported results as PaO2/FIO2, which causes me some concern. The authors did state that the conversion factor provided an approximation of FIO2, which was influenced by minute ventilation, breathing pattern, and gas leakage. I feel that an approximation of FIO2 cannot accurately predict PaO2/FIO2 where a completely closed system and accurate FIO2 is not provided. I found one abstract2 that used the formula to help rapidly predict correlation of SpO2/FIO2 in non-intubated patients as a surrogate to arterial blood gas for determining PaO2/FIO2 in emergency room patients, which may be a novel noninvasive way to assess respiratory failure.3–5
I could not find any reference to the formula to validate and verify an FIO2 via a port for NIV. I have used REMstar NIV machines (Philips Respironics, Murrysville, Pennsylvania) for several decades, and the general procedure limits oxygen to no more than 10 L for FIO2 approximately 0.4–0.5. I would need a machine that has a blender that would guarantee a delivered FIO2 for higher concentrations to obtain an accurate PaO2/FIO2. Examples of calculated flows based on the formula would be as follows: 5 L = 36%, 10 L = 51%, 15 L = 66%, or 20 L = 81%.
I recently cared for a patient with acute hypoxemic respiratory failure and an SpO2 of 89% on 6 L nasal cannula. The patient was placed on a CPAP device without an oxygen blender as I waited for a different machine with a blender. No matter what flow, based on the limitations of that machine, the saturation did not change. The patient required an FIO2 of >0.6 before the SpO2 began to increase. At 8, 10, 15, and 20 L bled into the mask port, SpO2 remained doggedly fixed at 89–90%. Indeed, the limitations on this device did not agree with the formula for FIO2 described in the paper.
The use of this equation may represent some false acceptance that the FIO2 is truly delivered to the patient and may lead to false assumptions regarding the seriousness of the subject's condition. Although the paper has merit with regard to volume or pressure targeting, the authors should have reported flow and PaO2 so that readers could make their own assumptions about oxygenation.
Footnotes
Ms Couture has disclosed a relationship with Philips Respironics.
- Copyright © 2017 by Daedalus Enterprises